Clinical Immunology (Orlando, Fla.)
-
Publication Venue For
- Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.. 160:14-23. 2015
- T.59. The Composition of the Primary Immunoglobulin Repertoire Influences HIV gp140 Epitope Selection. 131:S66-S67. 2009
- Idiopathic neutropenia of childhood is associated with Fas/FasL expression.. 129:438-447. 2008
- Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro.. 126:345-352. 2008
- Long-term tolerance to allogeneic thymus transplants in complete DiGeorge anomaly.. 126:277-281. 2008
- A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE.. 126:189-201. 2008
- Guidelines for assessing immunocompetency in clinical trials for autoimmune diseases.. 123:235-243. 2007
- Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006).. 123:139-147. 2007
- New developments in primary immunodeficiencies: Report on the 2006 CIS Primary Immunodeficiency Diseases Consortium Conference, June 1, 2006.. 121:369-371. 2006
- Normal interleukin-7 (IL7) levels and normal IL7 response to CD4 T lymphopenia in patients with multiple sclerosis and systemic sclerosis.. 121:118-119. 2006
- Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria.. 119:219-225. 2006
- The binding of sera of patients with SLE to bacterial and mammalian DNA.. 118:209-218. 2006
- Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID).. 117:133-143. 2005
- Humoral autoimmunity in mice overexpressing B cell surface CD19: vital role for MHC class II.. 116:257-264. 2005
- Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease.. 116:135-142. 2005
- Comparative potency of Ara h 1 and Ara h 2 in immunochemical and functional assays of allergenicity.. 115:302-312. 2005
- Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases).. 113:285-298. 2004
- Abnormal development of thymic dendritic and epithelial cells in human X-linked severe combined immunodeficiency.. 110:63-70. 2004
- Specificity and immunochemical properties of anti-DNA antibodies induced in normal mice by immunization with mammalian DNA with a CpG oligonucleotide as adjuvant.. 109:278-287. 2003
- The expression of plasma nucleosomes in mice undergoing in vivo apoptosis.. 106:139-147. 2003
- Bromelain treatment alters leukocyte expression of cell surface molecules involved in cellular adhesion and activation.. 104:183-190. 2002
- Corticosteroids may regulate epithelial cell differentiation and Hassall body formation in the thymus.. 103:S36-S36. 2002
- Thymic transplantation in complete DiGeorge syndrome.. 103:S77-S78. 2002
- Thymus transplantation after immunosuppression with thymoglobulin.. 103:S88-S88. 2002
- Tumor necrosis factor-alpha blockade: a novel therapy for rheumatic disease.. 103:231-242. 2002
- Zinc alpha-2-glycoprotein contributes to tumor-associated thymic atrophy.. 103:S36-S37. 2002
- Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease.. 103:161-168. 2002
- Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors.. 101:201-210. 2001
- Oral administration of IL-12 suppresses anaphylactic reactions in a murine model of peanut hypersensitivity.. 101:220-228. 2001
- The role of cpg sequences in the induction of anti-DNA antibodies.. 100:157-163. 2001
- Chemokines have diverse abilities to form solid phase gradients.. 99:43-52. 2001
- Hapten-induced primary and memory humoral responses are inhibited by the infusion of anti-CD20 monoclonal antibody (IDEC-C2B8, Rituximab).. 98:175-179. 2001
- CXCR3 and CCR5 ligands in rheumatoid arthritis synovium.. 98:39-45. 2001
- Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome.. 97:203-210. 2000
- Inhibition of murine macrophage IL-12 production by natural and synthetic DNA.. 96:198-204. 2000
- Extensive surface phenotyping of alveolar macrophages in interstitial lung disease.. 94:33-41. 2000
- A human anti-HIV autoantibody enhances EBV transformation and HIV infection.. 93:263-273. 1999
- HIV infection and the dynamic interplay between the thymus and the peripheral T cell pool.. 92:3-5. 1999
- Possible extrathymic development of nonfunctional T cells in a patient with complete DiGeorge syndrome.. 91:156-162. 1999
- Production of TNF-alpha by murine bone marrow derived mast cells activated by the bacterial fimbrial protein, FimH.. 90:420-424. 1999
- IL-21 Dictates the Quality and Maintenance of CD8 T Cell Responses during Acute and Chronic Infections 2010
- Sa.21. Evaluation of Microarray Surfaces and Arraying Parameters for Autoantibody Profiling 2008
- Carbohydrate Analysis of HIV Envelope Glycoprotein 2007
- Development of Regulatory T Cells After Thymus Transplantation in Subjects with Complete DiGeorge Syndrome 2007
- Sa.133. ELISpot Proficiency Testing for International Laboratories Participating in HIV Vaccine Trials 2006
- Parathyroid and thymus transplantation in complete DiGeorge syndrome. 2005
- Recurrent hemophagocytic lymphohistiocytosis syndrome (HLH) in a patient with common variable immune deficiency. 2005
- Time course of normalization of T cell receptor repertoire in a complete DiGeorge syndrome patient post-thymus transplantation. 2005
- Clinical evaluation of retroviral vectors for gene therapy of adenosine deaminase (ADA) deficiency. 2002